QNRX · Quoin Pharmaceuticals, Ltd.
$4.20
-0.09 (-2.10%)
At close · Jul 28
Going-concern doubt
— flagged May 7, 2026
Substantial doubt about the company's ability to continue as a going concern.
“we must raise additional capital to fund our operations in order to continue as a going concern”View the 10-Q filed May 7, 2026
Market Cap
$303.67M
Shares
72.30M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$0
FY2021
Net Income
-$15.8M
-75.6%
FY2025
Diluted EPS
-$52.50
FY2021
Operating Cash Flow
-$13.54M
-72.3%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| — | — | — | — | — | $0 | |
| $10.86M | $9.8M | $3.6M | $3.31M | $2.67M | $1.56M | |
| $6.6M | $6.49M | $5.93M | $6.07M | $6.58M | $4.5M | |
| $100K | $100K | $100K | $103.71K | $104.04K | $104.04K | |
| — | — | — | — | — | $1.09M | |
| $474.54K | $486.06K | $565.99K | $691.93K | -$123.79K | -$15.4M | |
| — | -$15.8M | — | — | — | — | |
| -$16.99M | -$15.8M | -$9M | -$8.7M | -$9.38M | -$21.46M | |
| — | — | — | -$8.69M | -$9.45M | — | |
| — | -$15.81M | — | — | — | — | |
| USD/shares | — | — | — | — | — | -$52.50 |
| USD/shares | — | — | — | — | — | -$52.50 |
| shares | — | — | — | — | — | 301.89K |
| shares | — | — | — | — | — | 301.89K |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.